Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2005
10/04/2005CA2238275C Metalloproteinase inhibitors
10/04/2005CA2185661C Novel iron chelator and inhibitor of iron-mediated oxidation
10/04/2005CA2152771C 7-o-ethers of taxane derivatives
10/04/2005CA2146763C Quinolone and acridinone derivatives for the treatment of urinary incontinence
09/2005
09/29/2005WO2005090992A2 Mptens as modifiers of the pten pathway and methods of use
09/29/2005WO2005090603A2 Method for diagnosing non-small cell lung cancer
09/29/2005WO2005090591A1 Oligosaccharides, preparation method and use thereof, and pharmaceutical compositions containing same
09/29/2005WO2005090576A1 Dna construct for preventing pertussis infection
09/29/2005WO2005090572A2 Compositions and methods for treating pancreatic cancer
09/29/2005WO2005090570A1 Therapeutic compositions and methods for treating diseases that involve angiogenesis
09/29/2005WO2005090564A1 Gene promoting vascular endothelial cell growth
09/29/2005WO2005090383A2 Process for preparing macrocyclic dipeptides which are suitable for the treatment of hepatitis c viral infections
09/29/2005WO2005090380A1 Pharmaceuticals salts of 3-o-(3',3'-dimethylsuccinyl) betulinic acid
09/29/2005WO2005090372A2 Platinum carboxylate anticancer compounds
09/29/2005WO2005090370A1 Pharmacologically active agents containing esterified phosphonates and methods for use thereof
09/29/2005WO2005090368A1 Synthetic membrane anchors
09/29/2005WO2005090367A1 Prodrugs of piperazine and substituted piperidine antiviral agents
09/29/2005WO2005090361A1 Trihemihydrate, anhydrate and hydrate forms of cefdinir
09/29/2005WO2005090350A1 Substituted piperidine compounds and methods of their use
09/29/2005WO2005090341A1 Azabicyclooctan-3-one derivatives and use thereof
09/29/2005WO2005090340A1 Piperidine-1-carboxamide derivative
09/29/2005WO2005090339A1 New antibacterial agents
09/29/2005WO2005090336A1 2-propanol and 2-propylamine derivatives and their use as glucocorticoid ligands
09/29/2005WO2005090332A1 Substituted quinazoline or pyridopyrimidine derivative
09/29/2005WO2005090331A1 Polymorphic and amorphous forms of 2,5-dimethyl-2h-pyrazole-3-carboxylic acid {2-fluoro-5-[3-((e)-2-pyridin-2-yl-vinyl)-1h-indasol-6-ylamino]-phenyl}-amide
09/29/2005WO2005090330A1 N-piperidine derivates as ccr3 modulators
09/29/2005WO2005090328A1 Heterocyclic compound and use thereof
09/29/2005WO2005090326A1 Antibiotic fki-1778 and process for producing the same
09/29/2005WO2005090322A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005WO2005090320A2 Triazole derivatives and method of using the same to treat hiv infections
09/29/2005WO2005090317A1 Non-nucleoside reverse transcriptase inhibitors
09/29/2005WO2005090316A1 HYDANTOINS HAVING RNase MODULATORY ACTIVITY
09/29/2005WO2005090315A1 Novel compounds as opioid receptor modulators
09/29/2005WO2005090312A1 5-aminoalkylpyrazole derivatives as pesticidal agents
09/29/2005WO2005090309A1 1,2-dihydroquinoline derivatives and method for using the same to treat hiv infection
09/29/2005WO2005090308A1 Process for the synthesis of a cxcr4 antagonist
09/29/2005WO2005090305A1 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension
09/29/2005WO2005090301A1 Crystalline form of atorvastatin hemi calcium
09/29/2005WO2005090300A1 Novel benzyl(idene)-lactam derivatives
09/29/2005WO2005090299A2 Carbamates as hiv anti-viral agents
09/29/2005WO2005090298A1 Sulphonamide derivatives
09/29/2005WO2005090297A1 Sulphonamide derivatives
09/29/2005WO2005090296A2 N-substituted benzene sulfonamides
09/29/2005WO2005090287A2 Phenylethanolamine derivatives as beta-2 agonists
09/29/2005WO2005090285A1 Novel crystal of triterpene derivative
09/29/2005WO2005090278A1 Alphahydroxyacids with ultra-low metal concentration
09/29/2005WO2005089872A2 Treatment of local pain
09/29/2005WO2005089871A1 Of at use of an antagonist compound of at least one receptor selected from a group comprising beta-adrenergic receptors, a at1, 5-ht5 and galanin receptor for preparing a pharmaceutical composition for treating rosacea
09/29/2005WO2005089814A1 X-ray visible drug delivery device
09/29/2005WO2005089806A1 Cream-gel containing ivermectin
09/29/2005WO2005089804A2 Combinations of hmg-coa reductase inhibitors and alpha1 adrenergic receptor antagonists
09/29/2005WO2005089803A2 Pharmaceutical compositions for the treatment of skin diseases comprising a combination of epinastine and one or more additional minerals or one or more crude drugs
09/29/2005WO2005089801A1 Method of preventing ultraviolet ray-induced apoptosis
09/29/2005WO2005089800A1 PHARMACEUTICAL COMPOSITION CONTAINING hsHRD3
09/29/2005WO2005089785A1 Acerola leaf extract-containing blood sugar level increase inhibitor and age formation inhibitor, and food containing them
09/29/2005WO2005089780A1 Composition against aids virus and method of selectively inactivating virus-infected cells
09/29/2005WO2005089779A2 Rapidly disintegrating taste-masked tablet
09/29/2005WO2005089778A1 Biodegradable polyurethane and polyurethane ureas
09/29/2005WO2005089777A1 A method for inhibiting cancer cell proliferation or increasing cancer cell apoptosis
09/29/2005WO2005089776A1 Algin oligosaccharides and the derivatives thereof as well as the manufacture and the use of the same
09/29/2005WO2005089775A1 Treatment and prevention of enterotoxigenic escherichia coli diarrhoeas
09/29/2005WO2005089774A1 D-ribose for improving depression-like symptoms
09/29/2005WO2005089773A1 Control of feeding behavior by changing neuronal energy balance
09/29/2005WO2005089772A2 Prevention of loss of tight cell junctions using carbohydrate-containing compositions
09/29/2005WO2005089771A1 Pharmaceutical composition comprising a benzodiazepine derivative and a inhibitor of the rsv fusion protein
09/29/2005WO2005089770A1 Benzodiazepines for treating or preventing or preventing rsv infection
09/29/2005WO2005089769A1 Pharmaceutical composition comprising a benzodiazepine derivative and an inhibit or of the rsv fusion protein
09/29/2005WO2005089768A1 Intranasal benzodiazepine compositions
09/29/2005WO2005089767A1 Use of aminopterin for treating cancer and inflammatory disorders
09/29/2005WO2005089766A1 Novel use for pde5 inhibitors
09/29/2005WO2005089765A1 Enzyme cofactor combination for supplementing pyruvate dehydrogenase and alpha ketogluterate dehydrogenase complexes
09/29/2005WO2005089764A1 Carboline derivatives useful in the inhibition of angiogenesis
09/29/2005WO2005089763A1 Imidazopyridine and imidazopyrimidine derivatives as antibacterial agents
09/29/2005WO2005089762A2 Pharmaceutical composition of (+)-erythro-mefloquine and its use in the treatment of an inflammatory condition
09/29/2005WO2005089761A1 Combination for treating inflammatory diseases
09/29/2005WO2005089760A1 8-hydroxy-5-[(-hydroxy-2-[[ (1r)-2-(4-methoxyphenyl)-1-methylethyl] amino ][ethyl] -2(1h)-quinolinone monohydrochloride in crystalline form and the process for its preparation
09/29/2005WO2005089758A1 Methods and compositions for the treatment of conditions related to gastric acid secretion
09/29/2005WO2005089757A1 Sns-595 and methods of using the same
09/29/2005WO2005089756A1 Sns-595 and methods of using the same
09/29/2005WO2005089755A1 Aqueous composition comprising thiazole derivative
09/29/2005WO2005089753A2 Daao inhibiting bξnzisoxazoles and their use for the treatment of mental disorders
09/29/2005WO2005089752A2 Tetra-cyclic carboline derivatives for inhibiting angiogenesis
09/29/2005WO2005089751A2 Use of metronidazole for preparing a pharmaceutical composition for treating a cutaneous inflammation
09/29/2005WO2005089750A2 Use of metronidazole for preparing a pharmaceutical composition for treating pathologies related to the b-type receptor of interleukin 8 and/or to a pacap type 1 receptor
09/29/2005WO2005089749A2 Use of metronidazole for preparing a pharmaceutical composition for treating a cutaneous vascularisation disorder
09/29/2005WO2005089748A1 Combination for treating inflammatory diseases
09/29/2005WO2005089746A1 Dosage titration for treatment of cognitive disorders
09/29/2005WO2005089745A1 Salvinorin derivatives and uses thereof
09/29/2005WO2005089744A2 Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
09/29/2005WO2005089743A1 Therapeutic agent for renal anemia
09/29/2005WO2005089742A1 Medicine for prevention or treatment of frequent urination or urinary incontinence
09/29/2005WO2005089741A2 The treatment of inflammatory disorders and pain using beta-aminoalcohols
09/29/2005WO2005089740A1 Coenzyme q composition with long-term persistence in blood
09/29/2005WO2005089739A1 Medical emulsion of perfluororganic compounds and method for the production thereof
09/29/2005WO2005089738A2 Use and administration of bacterial efflux pump inhibitors
09/29/2005WO2005089737A2 Materials and methods for inhibiting wip1
09/29/2005WO2005089736A2 Methods for treating inflammatory and autoimmune diseases
09/29/2005WO2005089734A2 Creatine salt enhanced nutritional and therapeutic efficacy and compositions containing same
09/29/2005WO2005089733A2 Anti-adhesive compounds to prevent and treat bacterial infections
09/29/2005WO2005089732A1 Use of a 5-ht3 receptor antagonist for the manufacture of a medicament for the treatment of non-digestive tract derived abdominal disorders associated with pain
1 ... 4521 4522 4523 4524 4525 4526 4527 4528 4529 4530 4531 4532 4533 4534 4535 4536 4537 4538 4539 4540 4541 ... 7860